scispace - formally typeset
H

Hong Li

Researcher at Guangzhou University of Chinese Medicine

Publications -  23
Citations -  1282

Hong Li is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Muscle hypertrophy & Angiotensin II. The author has an hindex of 14, co-authored 20 publications receiving 836 citations. Previous affiliations of Hong Li include Sun Yat-sen University & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Cardiovascular actions and therapeutic potential of tanshinone IIA.

TL;DR: This review focuses on the protective effects and the mechanism of action of TS in the cardiovascular system, and provides a novel perspective on clinical use of TS.
Journal ArticleDOI

Curcumin, the golden spice in treating cardiovascular diseases.

TL;DR: This review systematically analyze the preclinical studies of curcumin in CVDs such as cardiac hypertrophy, heart failure, drug-induced cardiotoxicity, myocardial infarction, atherosclerosis, abdominal aortic aneurysm, stroke and diabetic cardiovascular complications.
Journal ArticleDOI

Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6.

TL;DR: It is revealed that Nmnat2 protein expression and enzyme activity were down‐regulated during cardiac hypertrophy, and suggested that modulation of Nmn at2 activity may be beneficial in cardiachypertrophy.
Journal ArticleDOI

Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1.

TL;DR: It is demonstrated that a novel HO-1-dependent mechanism is involved in the regulation of cholesterol balance by Tan, which reduces the content of macrophages, cholesterol accumulation, and the development of atherosclerotic plaque in apolipoprotein E-deficient mice.